Bunge's Processing Margins Will Reveal Whether the Crush Recovery Has Actually Begun

Bunge Global (BG) reports first-quarter 2026 earnings before the market opens on Tuesday, April 29, with analysts expecting a sharp year-over-year decline in profitability amid challenging conditions in the global agribusiness sector. The central question: can the company stabilize margins and demonstrate operational resilience in a period marked by compressed crush spreads and volatile commodity markets? With the stock trading near recent highs and analysts maintaining a bullish stance, the earnings release will test whether BG's integrated value chain can offset near-term headwinds.

Part 1: Earnings Preview

Bunge Global is a leading agribusiness and food company that processes oilseeds and grains, produces sugar and bioenergy, and supplies fertilizers and other agricultural inputs. The company operates an integrated value chain spanning origination, processing, and distribution, serving food processors, livestock producers, and retail customers worldwide. Through its network of processing plants, port terminals, and logistics assets, Bunge handles a diverse portfolio of commodities including soybeans, corn, wheat, vegetable oils, and sugarcane.

Bunge reports Q1 2026 results before the market opens on April 29, with the consensus calling for $0.97 per share on revenue of approximately $23.26 billion. The company most recently reported $1.99 per share for Q4 2025, beating estimates by 9.34%. Year-over-year, the Q1 estimate represents a 46.41% decline from the $1.81 reported in Q1 2025, reflecting the challenging operating environment facing the agribusiness sector.

Three key themes define this earnings story. Crush margin compression remains the dominant narrative, as soybean processing spreads have narrowed significantly due to oversupply conditions and weak demand from China. Analysts are watching whether BG's diversified geographic footprint and integrated operations can partially offset these headwinds. Fertilizer segment performance is the second critical factor, with investors looking for signs of stabilization in input costs and farmer demand as planting season progresses. Finally, capital allocation and the Viterra integration will be scrutinized—the company's ability to execute on synergies from its recent acquisition while maintaining shareholder returns through dividends and buybacks will signal management's confidence in the medium-term outlook.

Leading analysts remain constructive despite near-term pressures. BMO Capital Markets raised its price target to $150, citing BG's "unmatched global footprint" and ability to capture value across cycles. Barclays lifted its target to $145, emphasizing the company's "structural advantages in origination and logistics." However, HSBC struck a more cautious tone with a $116 target and Hold rating, noting that "margin recovery may take longer than consensus expects" given persistent oversupply in key markets.

Part 2: Historical Earnings Performance

Bunge has demonstrated consistent execution over the past four quarters, beating analyst estimates in every report. The company delivered its strongest outperformance in Q1 2025 with a 42.52% surprise, posting $1.81 versus the $1.27 consensus. The magnitude of beats has moderated since then—Q2 2025 saw a 10.08% surprise ($1.31 vs. $1.19), Q3 2025 came in 1.79% above expectations ($2.27 vs. $2.23), and Q4 2025 beat by 9.34% ($1.99 vs. $1.82).

The pattern reveals a company that has consistently found ways to exceed lowered expectations, even as absolute profitability has declined year-over-year. The Q1 2025 blowout was driven by exceptional South American crop origination and favorable timing in the oilseed processing cycle. Subsequent quarters showed more modest beats as crush margins normalized and the company lapped tougher comparisons. The trend suggests management has maintained operational discipline and cost control, though the shrinking magnitude of surprises indicates less room for upside as analysts have recalibrated models to reflect the new margin environment.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Bunge typically reports before market open, meaning Day 0 captures the first full trading session reaction while Day +1 reflects follow-through momentum.

Historical price action shows moderate volatility around earnings, with an average absolute Day 0 move of 3.86% and Day 0 range of 5.21%. The Day +1 follow-through averages 1.43% with a 3.80% range, indicating most of the price discovery occurs in the initial session. The most dramatic reaction came in Q2 2024 (July 31, 2024) when the stock dropped 8.14% on Day 0 following a disappointing outlook, demonstrating that guidance matters as much as the headline beat. More recently, reactions have been muted—the February 2026 report saw just a 0.30% Day 0 gain despite the earnings beat, suggesting the market is focused on forward indicators rather than backward-looking results. Investors should expect a mid-single-digit percentage move in the initial session, with direction likely determined by management's commentary on crush margins and full-year guidance rather than the Q1 beat/miss alone.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 6.23% through the May 15 expiration, which sits above the 3.86% average historical Day 0 move but below the 5.21% average Day 0 range. This suggests options traders are anticipating elevated volatility relative to recent earnings reactions, possibly reflecting uncertainty around the magnitude of margin pressure and management's ability to reaffirm full-year guidance in a challenging environment.

Part 3: What Analysts Are Saying

Analysts maintain a bullish stance on Bunge heading into earnings, with the consensus rating at 4.67 out of 5.00 (between Buy and Strong Buy). The breakdown shows 7 Strong Buy ratings, 1 Moderate Buy, and 1 Hold, with no sell recommendations. The average price target of $133.00 implies 5.3% upside from the current price of $126.36, with a range spanning from $110.00 (low) to $150.00 (high).

Sentiment has deteriorated slightly over the past month, with the consensus rating edging down from 4.70 as one analyst moved from Strong Buy to Moderate Buy. Despite this modest shift, the overall posture remains decidedly positive—78% of analysts rate the stock a Strong Buy, reflecting confidence in the company's long-term competitive position even as near-term earnings face pressure. The $133 price target suggests analysts view current levels as attractive entry points, with the bull case (represented by the $150 high target) implying 18.7% upside for investors willing to look through the Q1 weakness. The lone Hold rating from HSBC at $116 serves as a reminder that margin recovery timelines remain uncertain, but the overwhelming majority of the Street sees BG's integrated model and global scale as durable advantages worth owning through the cycle.

Part 4: Technical Picture

Bunge enters earnings with strong technical momentum, as the Barchart Technical Opinion registers an 88% Buy signal—unchanged from last week but down from 100% Buy a month ago. The stock is trading above all major moving averages, including the 5-day ($125.50), 10-day ($123.81), 20-day ($124.92), 50-day ($123.03), 100-day ($112.81), and 200-day ($99.31), indicating a well-established uptrend across all timeframes.

Timeframe Analysis:

• Short-term (100% Buy): Maximum bullish signal indicates strong near-term momentum heading into the earnings release
• Medium-term (100% Buy): Sustained buy signal confirms the intermediate-term trend remains firmly positive
• Long-term (100% Buy): Full buy reading reflects a powerful long-term uptrend, with the stock up 27% from its 200-day moving average

Trend Characteristics: The combination of Strong strength and Average direction suggests the uptrend is well-established and durable, though momentum may be moderating slightly after the recent rally—a healthy consolidation pattern heading into a potentially volatile earnings event.

The technical setup is supportive heading into earnings, with the stock holding above all key moving averages and maintaining proximity to recent highs near $131.93. The 20-day moving average at $124.92 now serves as initial support, with the rising 50-day at $123.03 providing a secondary floor. The 27% premium to the 200-day moving average suggests the stock has priced in considerable optimism, meaning any disappointment on margins or guidance could trigger profit-taking back toward the $123-$125 support zone. Conversely, a constructive outlook could propel BG toward the $133-$135 analyst target cluster, with the $150 bull case in play if management signals an inflection in crush economics.